Nikhil Prasad Fact checked by:Thailand Medical News Team Jan 16, 2025 7 hours, 23 minutes ago
Medical News: A recent study conducted by researchers from The Jackson Laboratory, St. Jude Children’s Research Hospital, Weill Cornell Medicine, and Baylor Institute for Immunology Research in America, has unveiled significant differences in how infants respond to respiratory syncytial virus (RSV) and SARS-CoV-2 infections. These findings offer critical insights into the immune mechanisms at play in these vulnerable populations and may pave the way for improved clinical interventions.
Distinct Immune Responses to RSV and SARS-CoV-2 in Infants
Study Overview and Methodology
Respiratory infections pose a significant risk to infants due to their underdeveloped immune systems and small airways. RSV is a leading cause of hospitalizations among infants, with severe cases often leading to respiratory failure. Conversely, SARS-CoV-2, despite its global impact, typically causes milder disease in infants compared to RSV. To better understand these contrasting outcomes, researchers analyzed blood samples from infants diagnosed with RSV, SARS-CoV-2, and healthy controls.
This
Medical News team delves into their comprehensive approach, which included single-cell transcriptomics, epigenomics, and cytokine profiling. The team studied 66 infants, categorized based on disease severity, and utilized advanced sequencing techniques to explore immune responses at the cellular level.
Key Findings: Contrasting Immune Responses
-Reduced NK Cell Activity in RSV
One of the most striking findings was the reduced frequency and activity of natural killer (NK) cells in infants with severe RSV infections. NK cells, critical for controlling viral infections, showed decreased production of interferon-gamma (IFN-γ), a key antiviral molecule. Additionally, epigenetic analysis revealed diminished accessibility at regulatory sites essential for NK cell function, such as T-BET and EOMES binding sites. This impaired NK cell response may explain the heightened severity observed in RSV cases.
-Heightened Inflammatory Responses in SARS-CoV-2
In contrast, SARS-CoV-2 triggered robust pro-inflammatory responses. Infants with COVID-19 exhibited elevated levels of cytokines such as TNF-α, IL-6, and IL-8. The nuclear factor kappa B (NF-κB) pathway, which drives inflammation, was significantly upregulated in monocytes and T cells. This inflammatory profile contrasts sharply with the more subdued inflammatory response seen in RSV infections.
-Shared Interferon Responses
Both viruses induced strong interferon responses, a hallmark of antiviral immunity. Single-cell analysis revealed widespread upregulation of interferon-stimulated genes (ISGs) across immune cell types, including monocytes, dendritic cells, and T cells. However, epigenetic data indicated persistent ISG activation in SARS-CoV-2 infections, suggesting a longer-lasting immune memory compared to RSV.
-Distinct Patterns in Adaptive Immunity
RSV infections were associated with increased frequencies of CD4+ effector memory T cells (TEMRA) and regulatory T cells (Tregs). These changes indicate an effort to control inflammation and viral spread. On the other hand, SARS-CoV-2 infections showed heightened activation of naive T cells, driven by pro-inflammatory transcription factors such as AP-1 and NF-κB.
Clinical Implications of the Findings
These findings provide a detailed understanding of why RSV poses a greater threat to infants despite SARS-CoV-2 being more infectious overall. The impaired NK cell responses and reduced inflammatory signaling in RSV may hinder the ability to clear the virus effectively. Conversely, the intense inflammatory response in SARS-CoV-2, while potentially harmful, might explain the milder respiratory symptoms observed in infants.
Epigenetic Insights
The study also highlighted the role of epigenetic regulation in shaping immune responses. For instance, chromatin accessibility at interferon-related genes remained elevated in SARS-CoV-2-infected infants long after acute infection. This durable epigenetic memory could influence how these infants respond to future infections.
Conclusions
This research underscores the distinct immune responses of infants to RSV and SARS-CoV-2. RSV is marked by reduced NK cell activity and a blunted inflammatory response, while SARS-CoV-2 triggers robust inflammation and persistent epigenetic changes. These insights highlight the need for tailored therapeutic strategies to address the unique challenges posed by each virus. For RSV, enhancing NK cell function and boosting antiviral immunity could be key. For SARS-CoV-2, managing inflammation without compromising viral clearance may improve outcomes.
The study findings were published on a preprint server and are currently being peer reviewed.
https://www.researchsquare.com/article/rs-5640872/v1
For the latest on SARS-CoV-2 and RSV, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/link-between-infant-respiratory-microbiome-and-respiratory-syncytial-virus-rsv-severity-uncovered
https://www.thailandmedical.news/news/italian-study-highlights-increased-intracranial-abnormalities-in-newborns-exposed-to-sars-cov-2
https://www.thailandmedical.news/news/respiratory-syncytial-virus-infections-in-infants-causes-a-variety-of-long-term-health-issues-later-in-life
https://www.thailandmedical.news/news/infant-immune-responses-to-covid-19-show-key-differences-from-adults
https://www.thailandmedical.news/news/breaking-brazilian-study-reveals-potential-impact-of-covid-19-on-babies-vision
https://www.thailandmedical.news/news/breaking-covid-19-news-sars-cov-2-is-causing-new-onset-of-diabetes-mellitus-even-in-babies-a-few-months-old
Share
Tweet
Share
